EP Patent

EP1325739A1 — Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors

Assigned to Lipotec SA · Expires 2003-07-09 · 23y expired

What this patent protects

Liposomes encapsulating anticancerous drugs and the use thereof in the treatment of malignant tumours. The liposomes are coated with a lipopeptide composed of three substructures: a lipid fragment, an active oligopeptide and an oligopeptide spacer between the other two fragments.…

USPTO Abstract

Liposomes encapsulating anticancerous drugs and the use thereof in the treatment of malignant tumours. The liposomes are coated with a lipopeptide composed of three substructures: a lipid fragment, an active oligopeptide and an oligopeptide spacer between the other two fragments. Applicable in intravenous administration for treatment of malignant tumours.

Drugs covered by this patent

Patent Metadata

Patent number
EP1325739A1
Jurisdiction
EP
Classification
—
Expires
2003-07-09
Drug substance claim
No
Drug product claim
No
Assignee
Lipotec SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.